InMed Pharmaceuticals (INM) EPS (Diluted) (2021 - 2026)
InMed Pharmaceuticals (INM) EPS (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.31 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.82 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.91 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.11 |
| 10 | InMed Pharmaceuticals | 307,858.50 | -4.93 Mn | - | -0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.04 |
| Dec 31, 2025 | -0.51 |
| Sep 30, 2025 | -0.44 |
| Jun 30, 2025 | -1.34 |
| Mar 31, 2025 | -0.05 |
| Dec 31, 2024 | -3.64 |
| Sep 30, 2024 | -2.71 |
| Jun 30, 2024 | -5.07 |
| Mar 31, 2024 | -3.58 |
| Dec 31, 2023 | -3.71 |
| Sep 30, 2023 | -15.24 |
| Jun 30, 2023 | -2.75 |
| Mar 31, 2023 | -12.00 |
| Dec 31, 2022 | -18.24 |
| Sep 30, 2022 | -81.10 |
| Jun 30, 2022 | -280.66 |
| Mar 31, 2022 | -122.80 |
| Dec 31, 2021 | -154.64 |
| Sep 30, 2021 | -123.33 |